Legendary Trader: “Buy These Three Stocks Before this September Event”

Luke Lango believes an event scheduled for mid-September is set to trigger a massive market shock, potentially defining the winners and losers for the rest of the year.  

Wed, September 11 at 8:00PM ET
 
 
 
 
Register Here
Healthcare Stocks Icon

Healthcare Stocks

Healthcare encompasses a wide range of organized services to prevent, treat, and diagnose medical needs and mental illnesses. The $336 billion market is expected to grow at a compound annual growth rate of 8% until 2030, demonstrating the necessity of adequate healthcare. Healthcare companies, ranging from retailer CVS to insurance giant UnitedHealth, provide these services to a massive customer base.

The words "recession proof" written on a pink sticky note. bulletproof stocks

7 Recession-Resistant Stocks to Hold Onto for Dear Life in 2024

These seven recession-resistant stocks offer stability and potential growth even in challenging economic conditions.

Interest rate and dividend concept. Businessman with percentage symbol and up arrow, Interest rates continue to increase, return on stocks and mutual funds, long term investment for retirement. Dividend stocks

7 Dependable Dividend Stocks for Long-Term Income

Explore the best dividend stocks for long-term income excelling in the healthcare, retail, tobacco and home improvement markets.

medicine research, pharmaceutical background, LJPC stock

3 Pharmaceutical Stocks That Can Surge Higher Even if The Markets Correct

These are the pharmaceutical stocks to buy as they represent undervalued companies with a deep clinical pipeline that will support growth.

Other industries you might be interested in

Icon depicting a DNA strand

Biotech

Marijuana leaf

Cannabis

Icon depicting pills

Psychedelics

Recent Healthcare Stocks Articles

3 Hidden-Gem Growth Stocks to Buy for Multibagger Returns

By Faisal Humayun, InvestorPlace Contributor
These are the hidden-gem stocks that can deliver multibagger returns in the next five years.

Why Is Vaxart (VXRT) Stock Down 25% Today?

By William White, InvestorPlace Writer
Vaxart (VXRT) stock is taking a beating on Wednesday as investors react to the company announcing a proposed public share offering.

3 Biotech Stocks That Could Skyrocket in the Next 12 Months

By Muslim Farooque, InvestorPlace Contributor
These promising biotech stocks are risky but offer tremendous upside generating stellar long-term returns in the upcoming 12 months.

Why Are Gene Editing Stocks EDIT, NVTA, CRSP Up Today?

By Samuel O'Brient, InvestorPlace Reporter
Gene editing stocks are up today on news that Editas Medicine will present clinical data on June 12. Here's what this means for the sector.

Why Is Hoth Therapeutics (HOTH) Stock Up 83% Today?

By William White, InvestorPlace Writer
Hoth Therapeutics (HOTH) stock is rocketing higher on Tuesday thanks to the company announcing positive results from a preclinical trial.

Why Is Zura Bio (ZURA) Stock Up 9% Today?

By William White, InvestorPlace Writer
Zura Bio (ZURA) stock is on the rise Tuesday alongside a couple of positive pieces of news from the clinical-stage biotechnology company.

Why Is HTG Molecular Diagnostics (HTGM) Stock Down 42% Today?

By William White, InvestorPlace Writer
HTG Molecular Diagnostics (HTGM) stock is falling on Tuesday after the company announced a Chapter 11 bankruptcy filing.

3 Biotech Stocks to Sell in June Before They Crash and Burn

By Joel Baglole, InvestorPlace Contributor
The biotechnology sector has seen better days. From the Hedy days of the pandemic when companies were racing to develop a vaccine against Covid-19, the industry is now enduring a hangover as both demand and sales decline.

Why Is Greenlane (GNLN) Stock Down 90% Today?

By William White, InvestorPlace Writer
Greenlane (GNLN) stock is falling hard on Tuesday as the company's shares feel the effects of a one-for-10 reverse stock split.

Why Is T2 Biosystems (TTOO) Stock Up 17% Today?

By William White, InvestorPlace Writer
T2 Biosystems (TTOO) stock is rising on Tuesday after submitting a Breakthrough Device designation application for its Candida auris test.

3 Penny Stocks to Avoid Like the Plague in June

By Ian Bezek, InvestorPlace Contributor
Traders are looking for low-price stocks that can yield quick returns. However, these three high-risk penny stocks are headed for losses.

Can Pat Toomey Save Ocugen (OCGN) Stock?

By Chris MacDonald, InvestorPlace Contributor
Shares of OCGN stock received a boost this morning following the addition of some high-profile names to Ocugen's advisory board.

Why Is Bellerophon Therapeutics (BLPH) Stock Down 79% Today?

By William White, InvestorPlace Writer
Bellerophon Therapeutics (BLPH) stock is taking a massive beating on Monday after the company posted poor clinical trial results.

Why Is Mallinckrodt (MNK) Stock Down 23% Today?

By William White, InvestorPlace Writer
Mallinckrodt (MNK) stock is falling hard on Monday after the company received letters from concerned noteholders worried about financials.

3 High-Growth Stocks That Could Deliver Monster Returns by 2030

By Omor Ibne Ehsan
Investors should snap up these top high-growth stocks with monster potential before Wall Street starts going heavy on growth again.

Why Is Kiora Pharmaceuticals (KPRX) Stock Down 49% Today?

By William White, InvestorPlace Writer
Kiora Pharmaceuticals (KPRX) stock is falling hard on Friday after the company revealed details of a public share offering.

Why Is Better Choice (BTTR) Stock Up 27% Today?

By William White, InvestorPlace Writer
Better Choice (BTTR) stock is rising higher on Friday after the company announced the introduction of an AI chatbot to assist with sales.

3 Undervalued Biotech Stocks to Buy Before They Blast Off

By Chris Markoch, InvestorPlace Contributor
Fundamental analysis makes these three undervalued biotech stocks to buy plus they have other catalysts that make them compelling.

3 Retirement Stocks to Buy to Sleep Like a Baby

By Vandita Jadeja
Watch out for these safe retirement stocks if you are planning to build a retirement portfolio and sleep like a baby.
Load More Articles